Alpha Tau Medical Price Target Maintained With a $9.00/Share by HC Wainwright & Co.
Alpha Tau Medical Analyst Ratings
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $9
Buy Rating Reaffirmed for Alpha Tau Medical Ltd Amid Strong Clinical Results and Solid Financial Management
Citi Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $8
Buy Rating on Alpha Tau Medical Ltd. Amidst Promising Alpha DaRT Cancer Treatment Trials and Solid Financials
Alpha Tau Medical Analyst Ratings
Piper Sandler Reiterates Overweight on Alpha Tau Medical, Maintains $7 Price Target
Piper Sandler Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $7
Piper Sandler Reaffirms Their Buy Rating on Alpha Tau Medical Ltd (DRTS)
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target
Alpha Tau Medical Analyst Ratings
Alpha Tau Medical Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target
HC Wainwright & Co. : The Alpha Tau Medical (DRTS.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $9.00.
Alpha Tau Medical Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target
Buy Rating Affirmed: Anticipating Alpha Tau Medical's Clinical Milestones and Growth Potential in 2024
Alpha Tau Medical Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target